Teens as young as 13 referred for ketamine-linked bladder problems at UK clinic
· Medical Xpressedited by Swati Mestri, reviewed by Robert Egan
Swati Mestri
Scientific Editor
Meet our editorial team
Behind our editorial process
Robert Egan
Senior Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
peer-reviewed publication
trusted source
proofread
The GIST Add as preferred source
Non-prescribed ketamine use may start at age 13, data from a UK clinic dedicated to treating bladder problems associated with misuse of the drug suggest. The findings were published in a clinical letter in the Archives of Disease in Childhood.
Clinic attendees were also more likely to live in the most deprived neighborhoods and have experience of the care system.
The KIU (ketamine induced uropathy) clinic at Alder Hey Children's NHS Foundation Trust, Liverpool, was set up in May 2025 amid a rapid rise in referrals among under-16s for KIU—a progressive urinary tract condition associated with sustained use of the drug.
Symptoms include pain and burning when using the toilet (dysuria), urinary frequency/urgency and incontinence.
Analysis of the profiles of the first 60 patients referred to the clinic showed that their average age was 14, with ages ranging from 13–15, and that, for some patients, non-prescribed ketamine use had started when they were 13.
Around two-thirds (43) of the referrals were girls, and a similar number lived in the most deprived neighborhoods (IMD quintile 1). Sixteen of those referred had autism or ADHD, or both.
Nearly three-quarters (72%) had experienced some form of emotional trauma during childhood, and one in five had experience of the care system.
On average, the teens had been using ketamine for 1–2 years before referral and frequently reported concomitant use of other drugs (50%), alcohol (27%) and vapes (48%).
"These findings need to be considered when co-designing services for under-16s who use non-prescribed ketamine to ensure access improves inequalities and care is delivered in a trauma-informed and accessible way," the authors write.
Heavy ketamine use is not confined to Liverpool and surrounding areas, they point out. "Non-prescribed ketamine use and associated adverse effects are rising in the UK, including among under-18s, with 8.4% in treatment now reporting ketamine use."
Publication details
Who are the children and young people attending the UK's first ketamine- induced uropathy clinic for under 16s?: an early insight into sociodemographic features, Archives of Disease in Childhood (2026). DOI: 10.1136/archdischild-2026-330727
Journal information: Archives of Disease in Childhood
Key medical concepts
Clinical categories
UrologyPediatricsChildren's healthClinical pharmacologyCommon illnesses & Prevention Provided by British Medical Journal Who's behind this story?
Swati Mestri
Swati Mestri holds a bachelor's degree in Electronics Engineering and has worked as a content editor since 2019. She has experience editing research documents across technology, health care, and materials science, and has a particular interest in technology and space. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: Teens as young as 13 referred for ketamine-linked bladder problems at UK clinic (2026, September 22) retrieved 23 September 2026 from https://medicalxpress.com/news/2026-09-teens-young-ketamine-linked-bladder.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.